References
- Smith M R. Mantle cell lymphoma: advances in biology and therapy. Curr Opin Hematol 2008; 15: 415–421
- Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000; 95: 2253–2261
- Fu K, Weisenburger D D, Greiner T C, Dave S, Wright G, Rosenwald A, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005; 106: 4315–4321
- Montserrat E, Bosch F, Lopez-Guillermo A, Graus F, Terol M J, Campo E, et al. CNS involvement in mantle-cell lymphoma. J Clin Oncol 1996; 14: 941–944
- Oinonen R, Franssila K, Elonen E. Central nervous system involvement in patients with mantle cell lymphoma. Ann Haematol 1999; 78: 145–149
- Ferrer A, Bosch F, Villamor N, Rozman M, Graus F, Guttierrez G, et al. Cenral nervous system involvement in mantle cell lymphoma. Ann Oncol 2008; 19: 135–141
- Wlodarska I, Dierickx D, Vanhentenrijk V, Van Roosbroeck K, Pospisilova H, Minnei F, et al. Translocations targeting CCND2, CCND3 and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 2008; 111: 5683–5690
- Lu Y J, Williamson D, Clark J, Wang R, Tiffin N, Skelton L, et al. Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression. Proc Natl Acad Sci USA 2001; 98: 9197–9202